Dear friends and colleagues,
We are excited to introduce the Gibson Dunn Royalty Finance Tracker (https://www.gibsondunn.com/royalty-finance-tracker/) in conjunction with the launch of Biotech Briefings, where we have compiled all publicly announced royalty finance transactions amongst the most active funds that have occurred since January 1, 2020.
We see this as a general repository that the industry can use to reference current and past royalty finance transactions. The link is also accessible on our Biotech Briefings page (https://biotechbriefings.gibsondunn.com/), on the side under Useful Links.
If you are aware of a transaction that is not appropriately reflected, please email [email protected] with the applicable details.